Monthly Archives: May 2013

-

Sachs Cancer Bio Partnering Forum

130522 sachs_associates

The Sachs Cancer Bio Partnering Forum, presented by Sachs Associates, brings together business and scientific leaders from cancer research institutes, advocacy groups, pharmaceutical companies and biotech corporations, to assist in investment and funding opportunities. With over 300 representatives in these areas, this year’s presentations covered a wide range of topics, over the span of the two-day event.

Continue reading

-

Blossom Ball Raises Over $150K for Cancer Research

cy13-gala-marysville-header216050

On May 11, I was honored to be involved with hosting the Annual American Cancer Society’s (ACS) Blossom Ball with my family, OncoSec Medical was one of the sponsors and together we helped raise over $150,000 for cancer research and funding. As a biopharmaceutical company developing advanced-stage immunotherapy to treat skin cancer, I believe it is very important to be involved as an individual and represent OncoSec Medical with both the ACS and the group CEO’s Against Cancer. Below is an excerpt from the speech I gave that night at the fundraiser, providing an outline on the CEO’s Against Cancer program.

Continue reading

zoom
-

Why Electroporation?

Why electroporation? The reason is that electroporation is the most popular, most versatile, and most efficient transfection and transformation method available, for gene expression, in the widest variety of cell types.

In 1928, British medical officer Frederick Griffith conducted a series of classic experiments, with colonies of rough and smooth-coated Streptococcus pneumonia

Continue reading